Skip to content Skip to sidebar Skip to footer

Newsletter

Blue Chip Stocks

ResMed (ASX:RMD): Investors who bought the dip would be satisfied, but is there any growth left in this one?

ResMed (ASX:RMD) is one of the few ASX healthcare stocks that has successfully made it in the USA. And while Trump's tariffs have caused headaches for many healthcare stocks, ResMed might even be a beneficiary of them. Yes, there was a temporary dip in the share price, but shares are up more than 20% in…

ByNick SundichAugust 5, 2025

ASX stocks that will last forever: Here are our Top 5!

Everyone is looking for ASX stocks that will last forever - in other words, stocks that won't go bust and will be around for at least long as they are alive. Phillip Fisher once said,' If the job has been correctly done when a common stock is purchased, the time to sell it is-almost never'. Of…

ByNick SundichAugust 5, 2025

IperionX (ASX:IPX): It has become a A$1.7bn company, all thanks for US demand for titanium

Five years ago, IperionX (ASX:IPX) was just another small cap treading water with a market cap of $2.7m. Even in April 2023, it was only a tenth of what is now at under $200m, but it has created spectacular wealth for long-term investors. And it didn't happen by accident or coincidence. Luck may have been…

ByNick SundichJuly 30, 2025

Missed out on the Nvidia boom? Why not consider Nvidia suppliers that are publicly listed? Here’s our top 6!

If you want to benefit from the growth of Nvidia but don't have the confidence that you'll be able to reap the returns investors who got in earlier have made, you could invest in Nvidia suppliers. You see, the world's largest GPU supplier doesn't do it all 'in house', it relies on a number of suppliers.…

ByNick SundichJuly 29, 2025

$Ansell$

Ansell (ASX:ANN): More volatile than you’d expect for a PPE maker

Ansell (ASX:ANN) makes latex PPE (Personal Protective Equipment), particularly gloves. Latex gloves are no bottles of Dom Perignon, but they are often essential and you might think they are 'recession-proof', and so this company should only be going in one direction...up. In reality, its more complicated than that, although the company is in better shape…

ByNick SundichJuly 28, 2025

Capital Gains Tax on Shares: Here’s How It Works And Whether Or Not the 50% Discount Could Be Wound Back

Capital Gains Tax on Shares is one of the most notable taxes investors will face. Here is Stocks Down Under's Guide with what investors need to know. How CGT works and when do you have to pay it You have to pay a CGT on shares when a 'CGT event' occurs. This involves selling your shares…

ByNick SundichJuly 25, 2025

As ASX Reporting Season for FY25 Looms: Here’s An Investors Ultimate Guide

ASX Reporting Season is almost upon us once again. It is the most important time of the year for investors, a time many reconsider if their thesis still holds, many choose to buy into a stock or sell, some will receive dividends (either expectedly or unexpectedly) whilst others will be disappointed. While you may not…

ByNick SundichJuly 23, 2025

Is it possible for an investor to ‘time the market’ or is it just a myth?

Is it possible at all to time the market? Some will tell you it is possible, but they were probably just lucky and/or were not even trying to. Others will tell you it is not possible, but they are most likely trying to find an excuse to blame poor short-term performance. Let's take a serious look…

ByNick SundichJuly 21, 2025

Is the ASX 200 index overconcentration really as big a problem as its made out to be?

Index overconcentration is a term that's existed for decades, but has come increasingly to the fore in the last year or two on the ASX. We just had to write about this - the general term and the current perception of this issue on the ASX. In other words, how CBA accounts for a large…

ByNick SundichJuly 17, 2025

Scope One And Two Emissions: What Are They And Why They’re Important for Investors to Watch

Investors have long known that emissions have been a problem and increasingly scruitanised, but they may not know what so-called Scope One and Two Emissions are. But one thing that has brought these to the forefront is the new climate reporting regime that began in 2025. Firms with at least $500m in consolidated revenue, at least…

ByNick SundichJuly 16, 2025

the Kick-ass Multipurpose WordPress Theme

Blue Chip Stocks

ResMed (ASX:RMD): Investors who bought the dip would be satisfied, but is there any growth left in this one?

ASX stocks that will last forever: Here are our Top 5!

IperionX (ASX:IPX): It has become a A$1.7bn company, all thanks for US demand for titanium

Missed out on the Nvidia boom? Why not consider Nvidia suppliers that are publicly listed? Here’s our top 6!

Ansell (ASX:ANN): More volatile than you’d expect for a PPE maker

Capital Gains Tax on Shares: Here’s How It Works And Whether Or Not the 50% Discount Could Be Wound Back

As ASX Reporting Season for FY25 Looms: Here’s An Investors Ultimate Guide

Is it possible for an investor to ‘time the market’ or is it just a myth?

Is the ASX 200 index overconcentration really as big a problem as its made out to be?

Scope One And Two Emissions: What Are They And Why They’re Important for Investors to Watch

Sectors

Quick Links

Learn

2020, the Golden Year

Investing in the Year of the Rat

Market trouble spots to avoid in 2020

Blue Chip Stocks

Sectors

Quick Links

Learn

Add Your Heading Text Here